Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Insulin glargine and cancer--an unsubstantiated allegation.

× No keyword cloud information.

14 in total

1. Insulin glargine and incidence of cancer--an ongoing debate.

Authors: Norbert Hermanns; Bernd Kulzer
Journal: J Diabetes Sci Technol Date: 2010-03-01

2. Glucose-lowering therapies and cancer risk: the trials and tribulations of trials and observations.

Authors: J A Johnson; Y Yasui
Journal: Diabetologia Date: 2010-06-04 Impact factor: 10.122

Review 3. Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence.

Authors: J A Johnson; B Carstensen; D Witte; S L Bowker; L Lipscombe; A G Renehan
Journal: Diabetologia Date: 2012-04-04 Impact factor: 10.122

4. Protected graft copolymer (PGC) basal formulation of insulin as potentially safer alternative to Lantus® (insulin-glargine): a streptozotocin-induced, diabetic Sprague Dawley rats study.

Authors: Sandra Reichstetter; Gerardo M Castillo; ManShun Lai; Akiko Nishimoto-Ashfield; Aryamitra Banerjee; Alexei Bogdanov; Alexander V Lyubimov; Elijah M Bolotin
Journal: Pharm Res Date: 2011-12-28 Impact factor: 4.200

5. Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling.

Authors: L Sciacca; M F Cassarino; M Genua; G Pandini; R Le Moli; S Squatrito; R Vigneri
Journal: Diabetologia Date: 2010-04-28 Impact factor: 10.122

6. Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.

Authors: Xilin Yang; Gary T C Ko; Wing Yee So; Ronald C W Ma; Linda W L Yu; Alice P S Kong; Hailu Zhao; Chun-Chung Chow; Peter C Y Tong; Juliana C N Chan
Journal: Diabetes Date: 2010-02-25 Impact factor: 9.461

Insulin glargine and cancer--an unsubstantiated allegation.

1. Insulin glargine and incidence of cancer--an ongoing debate.

2. Glucose-lowering therapies and cancer risk: the trials and tribulations of trials and observations.

Review 3. Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence.

4. Protected graft copolymer (PGC) basal formulation of insulin as potentially safer alternative to Lantus® (insulin-glargine): a streptozotocin-induced, diabetic Sprague Dawley rats study.

5. Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling.

6. Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.

Review 7. Therapeutics of diabetes mellitus: focus on insulin analogues and insulin pumps.

8. Diabetes, insulin treatment, and cancer risk: what is the evidence?

Review 9. Insulin, insulin receptors, and cancer.

10. Insulin glargine controversy: a tribute to the editorial team at Diabetologia.